Yun-lian Hu

A retrospective study of the antibiotic-resistant phenotypes and genotypes of Helicobacter pylori strains in China.

Bangshun He, Shukui Wang, Chang-qing Yang, 2021, American journal of cancer research.

Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study

P. An, Fen Wang, Ying Han, 2022, Helicobacter.

Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial

He-sheng Luo, Xiang-wu Ding, Hui Long, 2022, Pharmacotherapy.

Efficacy and safety of Chinese herbal medicine Qirui Weishu capsule in treating chronic non-atrophic gastritis: A multicentre, double-blind, randomized controlled clinical trial.

Gang Zhao, Zhi-wei Huang, Yang Gong, 2022, Journal of ethnopharmacology.

Protective effects of curcumin against chronic alcohol-induced liver injury in mice through modulating mitochondrial dysfunction and inhibiting endoplasmic reticulum stress

Zhenqiang Zhang, Baoguang Liu, Baoying Wang, 2019, Food & nutrition research.

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome

Binbin Tang, Yun-lian Hu, Chengxia Su, 2023, Heliyon.

Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study

Pei-Yuan Li, Yun-lian Hu, Yang Lin, 2023, Journal of Gastroenterology.